<DOC>
	<DOCNO>NCT01774591</DOCNO>
	<brief_summary>The purpose research evaluate effect azilsartan medoximil blood pressure urinary aldosterone level postmenopausal female .</brief_summary>
	<brief_title>Effect Azilsartan Aldosterone Postmenopausal Females</brief_title>
	<detailed_description>The study randomize , placebo-controlled trial post-menopausal female stage 1 hypertension . The goal randomize 40 post-menopausal female stage 1 hypertension ass whether azilsartan reduces urinary aldosterone level . Additionally , small sub-study compare pre-menopausal post-menopausal female aldosterone level perform well presence aldosterone production fat cell culture subset 3 patient randomized trial .</detailed_description>
	<criteria>Female Ages 4570 Postmenopause : menstrual period one year Diagnosed Stage 1 hypertension Body Mass Index ( BMI ) great equal 28 Male Diagnosed Stage 2 hypertension Stage 1 hypertension require one agent Pregnancy attempt pregnancy Use oral contraceptive pill Use hormone replacement therapy Use steroid Stage 3 great kidney disease Diabetes mellitus untreated hypothyroidism hyperthyroidism primary hyperaldosteronism Cushing 's disease obstructive sleep apnea chronic illness , e.g . chronic liver disease NYHA class III great heart failure moderate severe lung disease</criteria>
	<gender>Female</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Post Menopause</keyword>
	<keyword>Female</keyword>
	<keyword>Obese</keyword>
</DOC>